Stocks
Vera Therapeutics, Inc.VERA
NASDAQHealthcareBiotechnology$27.99
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for rare kidney diseases, with its lead candidate targeting IgA nephropathy. Investors track Vera Therapeutics for its late-stage pipeline and potential to address an underserved patient population.
52W Range: $23.05-$56.05
Congressional Interest in Vera Therapeutics, Inc. (VERA)
No congressional trades have been disclosed for Vera Therapeutics, Inc. (VERA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading VERA?
No congressional trades found for this stock.